| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
61,456,000 |
| Market
Cap: |
864.69(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.9 - $16.15 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CareDx together with its subsidiaries, is a medicine company focused on the discovery, development and commercialization of diagnostic solutions for transplant patients and caregivers. Co. provides testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey, and is a provider of genomics-based information for transplant patients. Co.'s commercially available testing services consist of AlloSure® Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients, AlloMap® Heart, a solution for heart transplant patients, AlloSure® Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure® Lung.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
38,810 |
106,345 |
| Total Sell Value |
$0 |
$0 |
$359,527 |
$1,585,048 |
| Total People Sold |
0 |
0 |
2 |
3 |
| Total Sell Transactions |
0 |
0 |
9 |
21 |
| End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gagnon Neil |
10% Owner |
– – • |
2017-05-23 |
4 |
B |
$1.04 |
$2,066 |
I/I |
1,987 |
33,913 |
1.42 |
- |
|
| Gagnon Neil |
10% Owner |
– – • |
2017-05-23 |
4 |
B |
$1.04 |
$5,043 |
D/D |
4,849 |
878,777 |
2.37 |
- |
|
| Gagnon Neil |
10% Owner |
– – • |
2017-04-28 |
4 |
B |
$0.89 |
$13,453 |
D/D |
15,116 |
873,928 |
2.37 |
- |
|
| Goldberg Michael |
Director |
– • – |
2017-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,899 |
87,614 |
|
- |
|
| Bickerstaff George |
Director |
– • – |
2017-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,243 |
20,921 |
|
- |
|
| Hagstrom William A |
Director |
– • – |
2017-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,439 |
20,840 |
|
- |
|
| Cohen Fred E |
Director |
– • – |
2017-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,271 |
27,901 |
|
- |
|
| Miller Douglas S |
Director |
– • – |
2017-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,738 |
17,695 |
|
- |
|
| Snyderman Ralph |
Director |
– • – |
2017-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,384 |
41,407 |
|
- |
|
| Gagnon Neil |
10% Owner |
– – • |
2017-03-16 |
4 |
B |
$1.66 |
$41,299 |
I/I |
24,879 |
31,926 |
1.5 |
- |
|
| Gagnon Neil |
10% Owner |
– – • |
2017-03-16 |
4 |
B |
$1.66 |
$126,666 |
D/D |
76,305 |
858,812 |
2.45 |
- |
|
| Karlsson Anders |
See Remarks |
• – – |
2017-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
20,000 |
|
- |
|
| Maag Peter |
See Remarks |
• • – |
2017-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
107,250 |
|
- |
|
| Yee James P |
Chief Medical Officer |
• – – |
2017-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
45,598 |
|
- |
|
| Sninsky John Joseph |
Chief Scientific Officer |
• – – |
2017-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
24,000 |
|
- |
|
| Nelles Mitchell J |
Chief Operating Officer |
• – – |
2017-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
73,277 |
|
- |
|
| Constanti Charles |
Chief Financial Officer |
• – – |
2017-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Gagnon Neil |
10% Owner |
– – • |
2017-01-20 |
4 |
B |
$2.60 |
$7,618 |
I/I |
2,930 |
31,899 |
1.5 |
- |
|
| Gagnon Neil |
10% Owner |
– – • |
2017-01-20 |
4 |
B |
$2.60 |
$49,520 |
D/D |
19,046 |
782,507 |
2.37 |
- |
|
| Hagstrom William A |
Director |
– • – |
2017-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,213 |
17,401 |
|
- |
|
| Goldberg Michael |
Director |
– • – |
2017-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,299 |
74,715 |
|
- |
|
| Snyderman Ralph |
Director |
– • – |
2017-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,463 |
36,023 |
|
- |
|
| Cohen Fred E |
Director |
– • – |
2017-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,391 |
22,630 |
|
- |
|
| Miller Douglas S |
Director |
– • – |
2017-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,405 |
13,957 |
|
- |
|
| Bickerstaff George |
Director |
– • – |
2017-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,443 |
18,678 |
|
- |
|
800 Records found
|
|
Page 26 of 32 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.53 (3.91%) 
